Edition:
United States

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

30,636.82ZAc
26 Sep 2017
Change (% chg)

-571.18 (-1.83%)
Prev Close
31,208.00
Open
31,240.00
Day's High
31,352.00
Day's Low
30,406.00
Volume
947,225
Avg. Vol
1,184,666
52-wk High
32,372.00
52-wk Low
25,564.00

Chart for

About

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business... (more)

Overall

Beta: 0.60
Market Cap(Mil.): R142,449.41
Shares Outstanding(Mil.): 456.45
Dividend: 287.00
Yield (%): 0.92

Financials

  Industry Sector
P/E (TTM): -- 30.47 15.77
EPS (TTM): -- -- --
ROI: -- 14.26 15.19
ROE: -- 15.57 13.80

UPDATE 2-Aspen Pharmacare shifts the needle to injectibles

JOHANNESBURG, Sept 14 South Africa's Aspen Pharmacare expanded its anaesthetic drugs portfolio with a $766 million deal with AstraZeneca as it focuses on injectibles rather than making tablets.

Sep 14 2017

South Africa's Aspen Pharmacare posts 46 pct profit jump

JOHANNESBURG, Sept 14 South Africa's Aspen Pharmacare reported a 46 percent rise in full-year profit, buoyed by a revenue boost from an anaesthetics portfolio acquired from AstraZeneca and GlaxoSmithKline, the company said on Thursday.

Sep 14 2017

BRIEF-Aspen Pharmacare Holdings posts FY revenue 41,2 bln rand

* RAISED NORMALISED HEADLINE EARNINGS PER SHARE ("NHEPS") BY 16% TO 1 463 CENTS IN YEAR ENDED 30 JUNE 2017.

Sep 14 2017

CORRECTED-South Africa's Aspen Pharmacare flags jump in full-year profit

JOHANNESBURG, Aug 30 South African drugmaker Aspen Pharmacare said on Wednesday that it expects full-year profit to climb by as much as 48 percent from last year when it was hit by a writedown on its Venezuelan business.

Aug 30 2017

BRIEF-Aspen Pharmacare sees full-year NHEPS up 13 pct-18 pct

* ‍SEES FY NEHPS AT 1428.0 CENTS PER SHARE TO 1491.2 CENTS PER SHARE, UP 13 PERCENT - 18 PERCENT

Aug 30 2017

Pfizer, Roche and Aspen face South African probe into cancer drug prices

PRETORIA South Africa's competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines, the agency's chief said on Tuesday.

Jun 14 2017

UPDATE 2-Pfizer, Roche and Aspen face South African probe into cancer drug prices

* Aspen denies any wrong doing, committed to constructive engagement

Jun 13 2017

BRIEF-Aspen Pharmacare responds to South African Competition Commission investigation announcement

* Announcement that SACC will be investigating co for suspected abuse of dominance in respect of provision of cancer medication in South Africa

Jun 13 2017

Pfzer, Roche and Aspen face South Africa probe over cancer drug prices

PRETORIA, June 13 South Africa's competition watchdog has launched an investigation into three pharmaceutical companies suspected of charging excessively for cancer medicines, the agency's head Tembinkosi Bonakele said on Tuesday.

Jun 13 2017

French drugmaker Servier challenges 331 mln euro EU antitrust fine

LUXEMBOURG, June 6 French drugmaker Servier urged an EU court on Tuesday to slash a 331 million euro ($372 million) antitrust fine, saying regulators had committed multiple errors when they ruled against the company's pay-for-delay deals with generic rivals three years ago.

Jun 06 2017

Earnings vs. Estimates